EXCLUSIVE: Sunshine Biopharma Advances Its Lead Coronavirus Drug Candidate Into IND-Enabling Studies That Showed Broad-Spectrum SARS-CoV-2 Variant Activity In In-Vivo Study

Loading news article.

EXCLUSIVE: Sunshine Biopharma Advances Its Lead Coronavirus Drug Candidate Into IND-Enabling Studies That Showed Broad-Spectrum SARS-CoV-2 Variant Activity In In-Vivo Study | WAPE

EXCLUSIVE: Sunshine Biopharma Advances Its Lead Coronavirus Drug Candidate Into IND-Enabling Studies That Showed Broad-Spectrum SARS-CoV-2 Variant Activity In In-Vivo Study

Article summary

Related companies

Comments —